Daniel Joyner
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 2
- Prion Diseases and Protein Misfolding 1
- Receptor Mechanisms and Signaling 1
-
- Alzheimer's disease research and treatments 4
- Co-authors
- Bradley T. Hyman (6 shared papers)Tadafumi Hashimoto (3 shared papers)Tara L. Spires‐Jones (3 shared papers)Alberto Serrano‐Pozo (2 shared papers)David M. Holtzman (2 shared papers)Matthew P. Frosch (2 shared papers)Charles Glabe (1 shared paper)Preeti Putcha (1 shared paper)
- Journals
- Neuroscience (1 paper)The FASEB Journal (1 paper)Journal of Neurochemistry (1 paper)Brain (1 paper)Journal of Neuroscience (1 paper)
- Partner nations
- United StatesDenmarkGermany
In The Last Decade
Daniel Joyner
6 papers receiving 837 citations
Peers
Comparison fields: 5 of 77
- Neurology 187
- Physiology 578
- Neurology 230
- Cellular and Molecular Neuroscience 256
- Biological Psychiatry 24
Countries citing papers authored by Daniel Joyner
This map shows the geographic impact of Daniel Joyner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Joyner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Joyner more than expected).
Fields of papers citing papers by Daniel Joyner
This network shows the impact of papers produced by Daniel Joyner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Joyner. The network helps show where Daniel Joyner may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Joyner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 253 | |
| 2 | 2010 | 247 | |
| 3 | 2012 | 219 | |
| 4 | 2009 | 112 | |
| 5 | 2008 | 12 | |
| 6 | 2008 | 3 |
About Daniel Joyner
Daniel Joyner is a scholar working on Molecular Biology, Physiology, Cell Biology, Psychiatry and Mental health and Neurology, having authored 6 papers that have together received 846 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Endoplasmic Reticulum Stress and Disease (1 paper), Neurological disorders and treatments (1 paper), Prion Diseases and Protein Misfolding (1 paper), Cellular transport and secretion (1 paper) and Receptor Mechanisms and Signaling (1 paper). The work is most often cited by research in Neurology (187 citations), Physiology (578 citations), Neurology (230 citations), Cellular and Molecular Neuroscience (256 citations) and Biological Psychiatry (24 citations). Daniel Joyner has collaborated with scholars based in United States, Denmark and Germany. Frequent co-authors include Bradley T. Hyman, Tadafumi Hashimoto, Tara L. Spires‐Jones, Alberto Serrano‐Pozo, David M. Holtzman, Matthew P. Frosch, Charles Glabe, Preeti Putcha, Pamela J. McLean and Wolfgang Ruf. Their work appears in journals such as Neuroscience, The FASEB Journal, Journal of Neurochemistry, Brain and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.